The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE(-/-) mouse model. (Q50994560)
Jump to navigation
Jump to search
scientific article published on 14 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE(-/-) mouse model. |
scientific article published on 14 May 2013 |
Statements
1 reference
The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE(-/-) mouse model. (English)
1 reference
1 reference
Tracey Gaspari
1 reference
Iresha Welungoda
1 reference
Robert E Widdop
1 reference
Richard W Simpson
1 reference
14 May 2013
1 reference
10
1 reference
353-360
1 reference
4
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference